Trulieve Cannabis is trading 4.02% down now at $11.93 amid broader risk-off selling tied to surging oil prices, U.S.-Iran tensions, and renewed interest-rate concerns.
- No clear company-specific negative announcement was identified on September 9, 2026.
- Scheduled investor meetings at the ATB Cormark conference are not inherently negative, while the broader cannabis sector lacks a stronger fresh catalyst.
- The Dow, S&P 500, and Nasdaq are all lower, supporting a global market explanation.